Pralurbactam

Class: Beta-lactamase inhibitor

Spectrum of activity:	Gram-negative
Details of activity:	Indicated for complicated intra-abdominal infections
Combined with other compounds:	Yes
Description:	Synthetic compound; in combination with meropenem
Year first mentioned:	2017
Development status:	Active (as of 2024)

Chemical structure(s):
Canonical SMILES:	C1C[C@@H](C(=O)NOCCON=C(N)N)N2C[C@@H]1N(C2=O)OS(=O)(=O)O
Isomeric SMILES:	C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)NOCCON=C(N)N
InChI:	InChI=1S/C10H18N6O8S/c11-9(12)14-23-4-3-22-13-8(17)7-2-1-6-5-15(7)10(18)16(6)24-25(19,20)21/h6-7H,1-5H2,(H,13,17)(H4,11,12,14)(H,19,20,21)/t6-,7+/m1/s1
InChI Key:	HOJIPBUGHMYVQD-RQJHMYQMSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/155048066

External links:
Main Source:	https://patents.google.com/patent/US20200385385A1